Ten years after the groundbreaking FDA approval of checkpoint inhibitors, immuno-oncology (IO) is on the cusp of a new era. In BioSpace, Mural CEO Caroline J Loew, PhD reflects on the challenges, advances, and promise of ‘IO 2.0’—a wave driven by nimble biotech companies like ours, bringing innovative therapies beyond PD-1 inhibitors aiming to transform cancer care. Read on to see why we’re excited about this next chapter in IO: https://lnkd.in/gXan3Nmb
Mural Oncology’s Post
More Relevant Posts
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
To view or add a comment, sign in
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients
learn-more.com
To view or add a comment, sign in
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients
learn-more.com
To view or add a comment, sign in
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients
learn-more.com
To view or add a comment, sign in
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients
learn-more.com
To view or add a comment, sign in
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients
learn-more.com
To view or add a comment, sign in
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients
share.postbeyond.com
To view or add a comment, sign in
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients
learn-more.com
To view or add a comment, sign in
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients
learn-more.com
To view or add a comment, sign in
-
Watch our webinar to learn how a large cancer center implemented PGDx elioTM tissue complete. Our panel discusses the benefits of rapid biomarker identification, the potential to provide a clearer path to reimbursement and the research opportunities that are possible with PGDx elio tissue complete.
Implementation of an FDA-cleared tumor profiling assay to enable localized Precision Oncology testing for patients
learn-more.com
To view or add a comment, sign in
President & COO at Premier Pharma Executive Talent Sourcing, LLC
1moHi Caroline Best of luck with your continued success. Please keep me in mind when you need to hire top talent for your team